Daniel J Stieh

机构：Vaccine Research Institute of San Diego, Janssen (Switzerland), Johnson & Johnson (Netherlands), Johnson & Johnson (Brazil) · ORCID：0009-0003-8523-1528

发表论文 57 篇 · 总被引 1672 次 · h-index 20

代表论文

• Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial (2022 · Nature Microbiology · 被引 94)
• Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial (2024 · The Lancet Infectious Diseases · 被引 41)
• Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial (2024 · Nature Communications · 被引 21)
• Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study (2024 · EBioMedicine · 被引 17)
• Absolute quantitation of binding antibodies from clinical samples (2024 · npj Vaccines · 被引 14)
• Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features (2024 · Nature Communications · 被引 12)